Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Skrit37on Nov 20, 2020 8:32am
183 Views
Post# 31939380

RE:3000% Revenue increase Q/Q !!!!!

RE:3000% Revenue increase Q/Q !!!!!
Bully88 wrote: Cant wait to see the Analyst coverage on this progress

Very exciting times coming for Stage Zeroians!

For us intrigued on average tests done per day here is my spread

$1,500,000 / $75per test = 

20,000 tests completed. 

(6 working days per week as stated) = 72 working days in the quarter


20,000 tests / 72 working days = 

277.77 tests per day



 Tests Completed Revenue Per Test Total Revenue
1000  $    75.00  $        75,000.00
2000  $    75.00  $      150,000.00
3000  $    75.00  $      225,000.00
4000  $    75.00  $      300,000.00
5000  $    75.00  $      375,000.00
6000  $    75.00  $      450,000.00
7000  $    75.00  $      525,000.00
8000  $    75.00  $      600,000.00
9000  $    75.00  $      675,000.00
10000  $    75.00  $      750,000.00
20000  $    75.00  $  1,500,000.00
30000  $    75.00  $  2,250,000.00
40000  $    75.00  $  3,000,000.00
50000  $    75.00  $  3,750,000.00
60000  $    75.00  $  4,500,000.00
70000  $    75.00  $  5,250,000.00
80000  $    75.00  $  6,000,000.00
90000  $    75.00  $  6,750,000.00
100000  $    75.00  $  7,500,000.00


That is great progress.

Now calculate what we are going to be at in q4 with our new partnerships

Huge growth potential here!

cheers,

Bully


If this is indeed correct....we have plenty of capacity for increased covid testing...

so IMO..the proceeds we recieve from our current outstanding offering is more geared towards Aristotle expansion then i originally thought..esspecially lab expansion......its becomming even more clear the Aristotle is very close and will be at high volume immediatly as its announced...as soon as hospitals go back to normal function in the U.S and away from covid....thats when we will see the green light....until then...covid $$ rolls in...great situation...( this has been touched on in prospectus) but its very clear to me now

goodluck folks

<< Previous
Bullboard Posts
Next >>